The research company Respiratorius reported no revenue as planned during the second quarter. The operating loss was unchanged.Operating profit was -1.8 million kronor (-1.8). Net profit was -1.78 million kronor (-1.81), and earnings per share were -0.23 kronor (-0.25). Cash and cash equivalents amounted to 2.9 million kronor (3.1).Cash flow for the period was -1.7 million kronor (2.0)."Respiratorius continues to work in a cost-conscious manner and use resources efficiently. According tothe adopted budget, we assess that the current financing is sufficient to operate thebusiness through February 2027, which we currently assess provides goodconditions for the next steps in the company's development," comments CEO Johan Drott.Respiratorius, SEK millionQ2-2026Q2-2025ChangeNet sales00Operating profit-1.8-1.8Net profit-1.78-1.81Earnings per share, kronor-0.23-0.25Cash and cash equivalents2.93.1-6.5%